INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abbott Laboratories & Encourages Investors with Losses to Con...
October 13 2016 - 8:40PM
Business Wire
Khang & Khang LLP (the “Firm”) announces that it is
investigating claims against Abbott Laboratories (“Abbott” or the
“Company”) (NYSE: ABT) concerning possible violations of federal
securities laws.
If you purchased shares of Abbott and want more information,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
On April 28, 2016, Abbott announced a definitive agreement to
acquire St. Jude Medical Inc. (“St. Jude”). On October 11, 2016,
St. Jude issued a warning to physicians and patients that batteries
on thousands of its implantable defibrillators can quickly and
unexpectedly deplete. Two people died after their devices failed to
work correctly because of the drained battery, while 47 others
reported dizziness or fainting. The warning applied to devices made
before May 2015, which are in use by approximately 350,000 people
worldwide. Abbott stated that it still expects to close its
acquisition of St. Jude by the end of 2016.
If you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161013006677/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024